PharMEDium Services, LLC is recalling 17,045 units of 46 different IV medication lots, including Ephedrine Sulfate, Nicardipine HCl, Rocuronium Bromide, Hydromorphone, Fentanyl Citrate, and Succinylcholine Chloride. These medications are being recalled because they lack sterility assurance, meaning there is a risk the products may be contaminated with microorganisms. If a non-sterile drug is injected into a patient, it can lead to life-threatening infections or other serious health complications. These products were distributed nationwide in the United States and were primarily used in hospital and clinical settings.
The lack of sterility assurance means the IV medications could contain bacteria or fungi. Injecting a contaminated product directly into the bloodstream can cause serious systemic infections, sepsis, and potentially death, especially in patients with weakened immune systems.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.